Thailand Reverses Marijuana Legalization Amidst New Government

Regulations by 2FIRSTS.ai

Jan.11.2024

Thailand Reverses Marijuana Legalization Amidst New Government

Thailand's newly elected prime minister announces plans to re-ban recreational marijuana use within six months of taking office.

According to a report by hsbnoticias, Thailand's historic decision to legalize recreational marijuana seems to be in jeopardy as the country prepares for a government change in September 2023. The newly elected Prime Minister, Srettha Thavisin, has made a pact with the elite class and has promised to re-ban the recreational use of marijuana within the first six months of his term.

On January 9, 2024, the Ministry of Health in Thailand issued a legislation proposing fines or even imprisonment for violators. However, the consumption of cannabis in public places remains prohibited, and a complete industry has emerged around the recreational use of cannabis, including advertising and marketing.

Former Thai Minister of Health Anutin Charnvirakul stated that the intention behind the legalization of cannabis was not to encourage Thai people to consume it.

Thailand to Implement Medical Cannabis Policy. We never intended to endorse the recreational use of cannabis or promote its use in a manner that may cause discomfort to others," he stated.

References:

[1] Tailandia busca prohibir de nuevo el consumo recreativo de marihuana

Also Read:

[1] Reassessing E-cigarette and New Tobacco Legislation in Thailand

[2] WHO: Strengthening E-Cig Enforcement and Monitoring in Thailand to Prevent Addiction Tragedies

[3] Thai Medical Student Association Calls for Smoke-Free Parliament

#Traditional tobacco #Legislation #Asia #Thailand #Marijuana #Medical marijuana dispensary

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Pakistan Speeds Up Local Nicotine Pouch Production as PMI Unit Prepares to Launch ZYN

Pakistan’s smokeless, tobacco-free nicotine pouch market has expanded rapidly in recent years, prompting major tobacco companies to accelerate local investments, with Philip Morris Pakistan Ltd. (PMPKL) set to produce ZYN at its Sahiwal facility.

Dec.05 by 2FIRSTS.ai

Philip Morris International and an Italian Design Brand Launch Limited-Edition IQOS Collaboration, Debuting in Japan Before Expanding to 13 Travel Retail Markets

Philip Morris International (PMI) has partnered with Italian design brand Seletti on a limited-edition IQOS collaboration, unveiled at Milan’s Pirelli HangarBicocca. The collection features two models, launching first in Japan before rolling out to 13 global travel retail markets. PMI says the partnership leverages design and cultural storytelling to advance its smoke-free transition.

Oct.28 by 2FIRSTS.ai

Swedish Oral Pouch Manufacturer WiJo to Establish U.S. Production Base, Targeting March 2026 Start-Up

Swedish oral pouch manufacturer WiJo Pouches has announced plans to establish its first North American production facility in South Carolina, where it will lease a manufacturing site to produce nicotine, caffeine and functional pouch products. The project, expected to begin operations in March 2026 and create about 170 jobs, has secured tax incentive support from both state and county authorities.